VALEANT CANADA
VylomaMandate
The number one issue for all pharmaceutical treatments is enabling compliance. With some diseases unfortunately, there are no “cures”, only “management” therapy options. Genital warts is a disease that falls into this category. Our role was to communicate to physicians that there now existed a new pump delivery for the treatment of genital warts, all the while reinforcing the reoccurring cycle with a positive and encouraging approach. The clever use of the infinity symbol which also represented the 8 weeks of compliant treatment effectively communicated he course and timing of therapy.
![](https://3h.ca/wp-content/uploads/2018/04/Valaent_Vyloma_PrintAd_1.png)
![](https://3h.ca/wp-content/uploads/2018/04/Valaent_Vyloma_PrintAd_2.png)
![](https://3h.ca/wp-content/uploads/2018/04/Valaent_Vyloma_TearPad.png)
![](https://3h.ca/wp-content/uploads/2018/04/Valaent_Vyloma_DetailAid-1.png)